In the latest research into early antibiotic exposure and development of childhood conditions, a study of infants born ...

KARACHI: Health experts have reported a concerning increase in cases of a lung disease linked to exposure to pigeons, ...

Emrelis is the first FDA-approved treatment for previously treated patients with locally advanced or metastatic non-squamous ...

At just 22, Kaylee Engle dismissed the first strange lump near her breast-but when new ones appeared daily, she feared the ...

American depository receipts of Immutep rose after the company reported positive results from a trial of its combination treatment for non-small cell lung cancer. Immutep climbed 16% to $2.11 on ...

When you are diagnosed with COPD, it is important to remember that you are not alone. A healthcare team, which may include a ...

The antibody-drug conjugate is approved for previously treated advanced NSCLC patients with high c-Met protein overexpression ...

Following the approval, ABBV's Emrelis becomes the first FDA-approved therapy for previously treated advanced NSCLC patients ...

AbbVie's Emrelis is the first non-small cell lung cancer therapy approved for patients with high c-Met expression levels who ...

With lung tumour cases on the rise in India, robotic-assisted thoracic surgery offers a breakthrough—providing faster ...

Vaping is especially popular among teenagers and young adults, but fruity, candy-like flavours come with a chemical cost ...

Interim results from INSIGHT-003 suggest Immutep’s efti could reshape first-line treatment for non-small cell lung cancer ...